reference/20552345

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20552345

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	889
issn	0140-6736
issueIdentifier	8902
pageRange	886-889
publicationName	Lancet (London, England)
startingPage	886
bibliographicCitation	Levine M, Hirsh J, Arnold A, Gent M, Levine M, Arnold A, Bramwell V, Pritchard KI, Stewart D, Warr D, Goodwin P, Samosh M, Falanga A. Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. The Lancet. 1994 Apr;343(8902):886–9. doi: 10.1016/s0140-6736(94)90008-6.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43c3eb2c4943b8303043becb25528e12 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67dc7ea264d0bec5b8e21aaa17513f0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b441e3776c487438ab8059de153777d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bef28b738178279fc8af241202890f95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a12144e33fdec8d061f9f8c70b2758c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_854366cbff6e374196fa3a78036c6eab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38c1d66c8830ac671ef14f7775b54012 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_419ccd41399e610560746ddb8b98abd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28b2943f20662d1e7339787b1fd20f95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18740a7ff2815f85f82d9d5931a68f87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6066bb1ce0d0217560f4c8fa6087f04
date	1994-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/7908358 https://doi.org/10.1016/s0140-6736%2894%2990008-6
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470 https://portal.issn.org/resource/ISSN/0140-6736
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0022871
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014859Q000008 http://id.nlm.nih.gov/mesh/D013923Q000517 http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013923Q000139 http://id.nlm.nih.gov/mesh/D013924Q000139 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D014859Q000009 http://id.nlm.nih.gov/mesh/D013924Q000517 http://id.nlm.nih.gov/mesh/D009362
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9022 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10516 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9410 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788585

Total number of triples: 55.